VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Conventional approaches for ALL targeted therapies in allo-HSCT

Josep M. Ribera, MD, PhD, Germans Trias i Pujol University Hospital, Barcelona, Spain, discusses conventional approaches for acute lymphoblastic leukemia (ALL) targeted therapies in the setting of allogenic hematopoietic stem cell transplantation (allo-HSCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter